Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OPPS Rule Establishes Separate Palladium, Iodine G Codes For Brachytherapy

This article was originally published in The Gray Sheet

Executive Summary

The Centers for Medicare & Medicaid Services will establish two new G codes to track prostate brachytherapy procedures, under the 2003 hospital outpatient prospective payment system final rule

You may also be interested in...



APC Panel Advises CMS To Review Brachytherapy Proposed Payment Rates

High-dose-rate brachytherapy manufacturers Nucletron and Varian plan to survey all 600 U.S. hospitals performing the procedure in an attempt to convince CMS to raise the 2004 proposed payment rate under the hospital outpatient prospective payment system

APC Panel Advises CMS To Review Brachytherapy Proposed Payment Rates

High-dose-rate brachytherapy manufacturers Nucletron and Varian plan to survey all 600 U.S. hospitals performing the procedure in an attempt to convince CMS to raise the 2004 proposed payment rate under the hospital outpatient prospective payment system

Brachytherapy Procedure APCs Face Sharp Payment Drop Under OPPS Rule

Inadequate reimbursement for brachytherapy procedures in the 2004 hospital OPPS proposed rule would not be alleviated by provisions in the Medicare reform bill, according to the Coalition for the Advancement of Brachytherapy (CAB)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel